Allogeneic stem-cell transplantation in multiple myeloma patients at the Hematology Department of the University Medical Centre Ljubljana
Background: Multiple myeloma (MM) is an incurable malignant clonal plasma cell disorder. Allogeneic stem-cell transplantation (SCT) is a possible treatment for limited number of patients. It is associated with high treatment-related mortality (TRM), mainly due to complications related to graft versu...
Main Authors: | Barbara Skopec, Jožef Pretnar, Uroš Mlakar, Samo Zver |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2012-12-01
|
Series: | Zdravniški Vestnik |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/741 |
Similar Items
-
Incidence and treatment of multiple myeloma at the Department of Hematology of the University Medical Centre Ljubljana in the period 2008–2011
by: Samo Zver, et al.
Published: (2012-12-01) -
Treatment of patients diagnosed with primary immune thrombocytopenia at the Hematology Department of the University Medical Centre Ljubljana
by: Barbara Skopec, et al.
Published: (2012-12-01) -
Treatment of multiple myeloma at Clinical Department of Hematology, University Medical Centre Ljubljana with autologous hematopoietic stem cell transplantation in years 2014 and 2015
by: Samo Zver, et al.
Published: (2016-11-01) -
TREATMENT OF MULTIPLE MYELOMA PATIENTS WITH TANDEMAUTOLOGOUS HEMATOPOETIC STEM CELL TRANSPLANTATION IN SLOVENIJA
by: Aleksandra Zver, et al.
Published: (2008-04-01) -
Hematopoietic stem cell mobilization using plerixafor – single center experience at the University medical centre Ljubljana
by: Matjaž Sever, et al.
Published: (2012-12-01)